Insights

South Carolina Senate Approves Conservative Medical Cannabis Bill

LOS ANGELES- In a pivotal move for medical cannabis legislation, the South Carolina Senate has passed a bill aimed at legalizing medical cannabis for individuals with certain serious health conditions. This decision marks a significant step toward providing relief for patients within a framework designed to maintain strict control over the drug's production and distribution, ...

February 15th, 2024|
  • Seizure of contraband and unauthorized items at Archambault Institution

Florida Advances Bill to Restrict Hemp-Derived Cannabinoids

LOS ANGELES- A significant legislative development occurred in Florida on Monday as a House legislative subcommittee moved forward with a bill aimed at regulating psychoactive hemp-derived cannabinoids, including Delta 8 and Delta 10 THC. House Bill 1613, sponsored by Republican State Representative Tommy Gregory, seeks to address the burgeoning market of hemp products that have ...

February 15th, 2024|

U.S. Virgin Islands Sets Stage for Adult-Use Cannabis Market

LOS ANGELES- In a significant move for the U.S. Virgin Islands, the territory's Cannabis Board sanctioned a comprehensive set of rules and regulations for the adult-use cannabis sector on Tuesday, marking a pivotal advancement since the legalization was legislated in January of the previous year. This long-anticipated approval by the board lays the groundwork for ...

February 15th, 2024|

Cybin Inc. Reports Psychedelic Treatments and Financial Growth in Q3

LOS ANGELES- Cybin Inc., a development of next-generation psychedelic treatments for mental health disorders, today unveiled its unaudited financial outcomes for the third quarter ending December 31, 2023, alongside key business achievements. This period has been marked by significant advancements in the company’s psychedelic research, particularly within its CYB003 and DMT programs, showcasing Cybin’s commitment ...

February 15th, 2024|

New Mexico Embraces Drive-Thru Cannabis Dispensaries

LOS ANGELES- In a pivotal decision reflecting the evolving landscape of cannabis commerce, New Mexico has chosen to endorse the operation of drive-thru cannabis dispensaries, a move that underscores the state's commitment to convenience and the normalization of cannabis. This development came to light during the state's latest legislative session, where the proposition to sustain ...

February 15th, 2024|
  • Cannabis Cultivation Market

Pennsylvania’s Cannabis Market Poised for Expansion as Recreational Use Moves Closer to Reality

LOS ANGELES- Pennsylvania's cannabis industry is on the brink of a significant transformation as Governor Josh Shapiro pushes for the legalization of recreational marijuana use. In his recent budget address, the Democratic leader urged lawmakers to allow adults over the age of 21 to possess and use cannabis by July 1, with plans for retail ...

February 13th, 2024|

Michigan’s Cannabis Market Experiences Mixed Growth

LOS ANGELES- Michigan's cannabis industry has witnessed a varied growth pattern, with adult-use sales driving the market forward while medical cannabis sales face a significant decline. The state's cannabis sales increased by 17.1% compared to the previous year, showcasing a slower yet positive growth rate. However, the dynamics within the market present a contrasting picture. ...

February 13th, 2024|

Minnesota Mayor Arrested for Exceeding Legal Cannabis Cultivation Limits

NEW YORK- In an unexpected turn of events, the mayor of Winnebago, Minnesota, Scott Robertson, and his son Jacob Robertson, have been arrested for operating commercial-grade greenhouses to cultivate cannabis in quantities far exceeding the state's legal limit. The arrests were made following a collaborative investigation by multiple law enforcement agencies, initiated by an anonymous ...

February 12th, 2024|

Compass Pathways Launches Phase 3 Psilocybin Study in the UK for Treatment-Resistant Depression

Compass Pathways, a biotechnology firm at the forefront of mental health innovation, has initiated the UK segment of its global phase 3 study of COMP360 psilocybin therapy for treatment-resistant depression (TRD). This advancement, approved by the Medicines and Healthcare Regulatory Agency, marks a critical phase in the exploration of psilocybin as a potential treatment for ...

February 12th, 2024|

Idaho Legislators Propose Bill to Ban Out-of-State Cannabis Advertisements

LOS ANGELES- In a move reflecting Idaho's staunch stance on cannabis prohibition, state legislators are deliberating on a bill aimed at curtailing advertisements for cannabis products from neighboring states where it is legal. The proposed legislation comes in response to the visibility of billboards and other forms of advertising that promote out-of-state cannabis, sparking concern ...

February 11th, 2024|

atai Life Sciences Appoints Anne Johnson as Chief Financial Officer

NEW YORK – atai Life Sciences a pioneering  company specializing in mental health treatment innovations, today announced the promotion of Anne Johnson to Chief Financial Officer (CFO). Johnson, who has served as the interim CFO since October 2023 and Chief Accounting Officer since August 2022, will officially succeed Stephen Bardin in the CFO role. Bardin ...

February 9th, 2024|

Cybin Inc. Awarded Patents in Japan, Strengthening Global Psychedelic Research Efforts

NEW YORK— Cybin Inc. a biopharmaceutical industry dedicated to transforming mental healthcare with innovative psychedelic-based therapies, has achieved a significant milestone with the recent grant of two patents by the Japan Patent Office. These patents, numbered 2023-500532 and 2023-533436, mark a crucial step in the company's quest to develop next-generation treatments for mental health disorders, ...

February 8th, 2024|

Hawaii Lawmakers Deliberate on Trio of Cannabis Legalization Proposals

LOS ANGELES— In a pivotal legislative session, Hawaii's lawmakers are presented with three distinct proposals aimed at reforming the state's cannabis laws. These include two notable bills pushing for the legalization of adult-use cannabis, alongside the establishment of a regulatory framework, marking a significant moment in the state's approach to cannabis legislation. The proposals, introduced ...

February 7th, 2024|

Arizona Embarks on Psychedelic Therapy Frontier with Psilocybin Service Center Legislation

LOS ANGELES- In a significant step towards the integration of psychedelic therapy into mainstream healthcare, Arizona is positioning itself at the forefront of a growing movement. Bipartisan lawmakers have introduced groundbreaking legislation aimed at legalizing psilocybin service centers within the state, marking a bold expansion beyond current research efforts into the therapeutic applications of psychedelics. ...

February 5th, 2024|

New York Governor Calls State’s Cannabis Roll-Out a “Disaster”

NEW YORK- Governor Kathy Hochul of New York has openly criticized the state's approach to rolling out its adult-use cannabis market, describing the process as a "disaster." This candid admission comes amidst a series of legal challenges that threaten to further delay the licensing of new cannabis retailers in the state. The governor's comments reflect ...

February 5th, 2024|
  • Global Medical Marijuana Market, Legal Marijuana Market, Cannabis Packaging

Maine Explores On-Site Cannabis Consumption: A Leap Towards Inclusivity and Normalization

LOS ANGELES-Amid the serene backdrop of its pine-clad hills, Maine finds itself at the forefront of a significant legislative debate—one that could redefine the cannabis industry within its borders and potentially set a precedent for the nation. Lawmakers in the Pine Tree State are currently deliberating on a proposal that could introduce on-site cannabis consumption ...

February 1st, 2024|

Filament Health Corp. Gains FDA Approval for Psilocybin Clinical Trials

LOS ANGELES- The U.S. Food and Drug Administration (FDA) has recently granted an investigational new drug application to Vancouver-based Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) for its botanical psilocybin substance, PEX010. This approval marks a significant stride for Filament, enabling the firm to conduct clinical trials in the United States aimed at treating substance ...

January 31st, 2024|

Broad Support in Canada for Psilocybin Use in Palliative Care, New Study Reveals

LOS ANGELES — A recent Canadian study, published in the medical journal Palliative Medicine, has revealed significant public support for the use of psilocybin, a psychedelic compound, in treating existential dread among end-of-life patients. Conducted by a team led by Michel Dorval, a researcher at CHU de Québec-Université Laval Research Center and a professor at Université ...

January 25th, 2024|

FinCEN’s Corporate Transparency Act Has Arrived

NEW YORK- Enacted by Congress in 2021, the Corporate Transparency Act (CTA) went into effect on January 1, 2024 and affects more than 30 million American small businesses1 and many smaller foreign companies doing business in the United States. Unless exempted, these businesses must provide ownership information to the Treasury’s Financial Crimes Enforcement Network (FinCEN) ...

January 25th, 2024|

Organigram Advances in Cannabis Market with Strategic British American Tobacco Investment

LOS ANGELES- Organigram Holdings Inc., a significant player in the cannabis industry, has successfully closed the first tranche of a substantial investment from British American Tobacco's subsidiary, BT DE Investments Inc. This move marks a significant step in the Canadian company's expansion and diversification strategy. The first tranche involves the acquisition of 12,893,175 common shares ...

January 24th, 2024|
  • Ayr Wellness Announces Brand Launches in Massachusetts and Ohio

Ohio Cannabis Market Faces Challenges Amid Optimism for Adult-Use Expansion

LOS ANGELES- Ohio's medical cannabis market, one of the nation's most strictly regulated, showed signs of plateauing in 2023, with an increase of just 1.2% in annual sales compared to the previous year. This marks a significant slowdown from the explosive growth observed in the market's early years, according to a Crain’s Cleveland analysis. Despite ...

January 24th, 2024|

New Jersey Moves Forward with Cannabis Consumption Lounge Regulations

LOS ANGELES- The New Jersey Cannabis Regulatory Commission (CRC) is taking significant strides in the realm of cannabis consumption with the unanimous approval of regulations for consumption lounges, a pivotal development in the state's cannabis industry. The decision, made during a meeting on January 17, marks a progressive step towards actualizing these lounges in New ...

January 24th, 2024|

Revive Therapeutics Announces $3 Million Private Placement for Clinical and Operational Advancements

Revive Therapeutics Ltd. a prominent player in the biopharmaceutical sector, has recently announced its plan to initiate a significant private placement to fuel its ongoing and future projects. This strategic move, aimed at garnering up to $3 million in funding, represents a pivotal moment for the company's financial and clinical trajectory. Under the terms of ...

January 24th, 2024|
  • Ayr Wellness, Cannabis Retail

Indiana Residents Lean Toward Cannabis Legalization, New Poll Indicates

LOS ANGELES- As Indiana's legislators convene for a new session, the topic of cannabis legalization takes a prominent place in the agenda, bolstered by recent findings from the 2023 Hoosier Survey. Conducted by the Bowen Center for Public Affairs at Ball State University, the survey unveils a growing inclination among Indiana residents towards cannabis reform, ...

January 24th, 2024|

Study: Medical Cannabis Associated With Symptom Improvements In Patients With Major Depressive Disorder

ESSEN, Germany- A new study published in The Journal of Pharmacopsychiatry, reveals a link between the use of medical cannabis products and decreased levels of depression. German researchers investigated the use of medical cannabis in 59 outpatients diagnosed with major depressive disorder (MDD). While medical cannabis, including plant cannabis and cannabinoid treatments like dronabinol, became ...

January 24th, 2024|
Go to Top